Fredun Pharmaceuticals' board has approved a preferential issue of 6,44,360 equity shares at Rs 1250 each, raising Rs 80.54 crore in cash. Additionally, the company approved the allotment of 5,51,600 convertible warrants at an exercise price of Rs 1250 per warrant, with an initial subscription of Rs 17.23 crore. These actions aim to raise capital for the company.